Vicore Pharma Holding AB (publ) (STO: VICO)
Sweden
· Delayed Price · Currency is SEK 7.77
+0.21 (2.78%)
Nov 20, 2024, 5:29 PM CET
Vicore Pharma Holding AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 104.24 | - | - | - | - | - | Upgrade
|
| Gross Profit | 104.24 | - | - | - | - | - | Upgrade
|
| Selling, General & Admin | 50.06 | 44.6 | 37.53 | 21.61 | 24.99 | 26.88 | Upgrade
|
| Research & Development | 271.91 | 276.29 | 249.97 | 271.81 | 142.02 | 67.05 | Upgrade
|
| Operating Expenses | 321.96 | 320.89 | 287.49 | 293.42 | 167.01 | 93.92 | Upgrade
|
| Operating Income | -217.72 | -320.89 | -287.49 | -293.42 | -167.01 | -93.92 | Upgrade
|
| Interest Expense | - | -0 | -0.01 | -0.01 | -0.01 | -0.03 | Upgrade
|
| Interest & Investment Income | 24.22 | 10.54 | 0.91 | 0.65 | 0.82 | 0.16 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.95 | -0.62 | -1.75 | -1.83 | -0.07 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | -196.45 | -310.97 | -288.34 | -294.61 | -166.27 | -93.88 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.36 | -0.36 | -0.47 | -2.12 | 1.41 | 0.55 | Upgrade
|
| Other Unusual Items | - | - | - | - | 17.54 | - | Upgrade
|
| Pretax Income | -196.8 | -311.33 | -288.81 | -296.74 | -147.32 | -93.33 | Upgrade
|
| Income Tax Expense | -0.35 | -0.38 | -0.38 | -0.25 | -0.45 | -0.25 | Upgrade
|
| Net Income | -196.45 | -310.94 | -288.42 | -296.48 | -146.86 | -93.08 | Upgrade
|
| Net Income to Common | -196.45 | -310.94 | -288.42 | -296.48 | -146.86 | -93.08 | Upgrade
|
| Shares Outstanding (Basic) | 112 | 97 | 72 | 70 | 54 | 43 | Upgrade
|
| Shares Outstanding (Diluted) | 112 | 97 | 72 | 70 | 54 | 43 | Upgrade
|
| Shares Change (YoY) | 28.57% | 33.71% | 3.64% | 28.44% | 26.04% | 88.10% | Upgrade
|
| EPS (Basic) | -1.76 | -3.22 | -3.99 | -4.25 | -2.71 | -2.16 | Upgrade
|
| EPS (Diluted) | -1.76 | -3.22 | -3.99 | -4.25 | -2.71 | -2.16 | Upgrade
|
| Free Cash Flow | -181.24 | -249.58 | -299.92 | -265.17 | -119.94 | -87.15 | Upgrade
|
| Free Cash Flow Per Share | -1.62 | -2.58 | -4.15 | -3.81 | -2.21 | -2.02 | Upgrade
|
| Gross Margin | 100.00% | - | - | - | - | - | Upgrade
|
| Operating Margin | -208.86% | - | - | - | - | - | Upgrade
|
| Profit Margin | -188.45% | - | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -173.86% | - | - | - | - | - | Upgrade
|
| EBITDA | -226.64 | -317.47 | -283.88 | -290.06 | -163.65 | -92.81 | Upgrade
|
| EBITDA Margin | -217.41% | - | - | - | - | - | Upgrade
|
| D&A For EBITDA | -8.92 | 3.42 | 3.61 | 3.36 | 3.36 | 1.12 | Upgrade
|
| EBIT | -217.72 | -320.89 | -287.49 | -293.42 | -167.01 | -93.92 | Upgrade
|
| EBIT Margin | -208.86% | - | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.